Related Experiment Videos
Clinical management of asymptomatic myocardial ischemia
1Marshall University School of Medicine, Huntington, WV 25701-5490.
Insights
Silent myocardial ischemia, a precursor to heart attacks and sudden cardiac death, necessitates treatment. Understanding its mechanisms and exploring treatment options like risk factor modification and revascularization are crucial for managing ischemic heart disease.
Area of Science:
- Cardiology
- Cardiovascular Disease Research
Background:
- Silent myocardial ischemia significantly contributes to cardiac morbidity and mortality, including myocardial infarction and sudden cardiac death.
- Asymptomatic myocardial ischemia is prevalent and linked to adverse ischemic heart disease events.
- Two primary mechanisms, increased myocardial demand in obstructive coronary disease and dynamic coronary stenosis, are proposed for ischemic episodes.
Purpose of the Study:
- To highlight the clinical significance of silent myocardial ischemia.
- To review proposed pathophysiologic mechanisms of transient myocardial ischemia.
- To outline current treatment strategies for silent myocardial ischemia.
Main Methods:
- Review of existing literature on silent myocardial ischemia.
- Analysis of proposed pathophysiologic mechanisms.
- Categorization of treatment options into conservative, moderate, and aggressive approaches.
Main Results:
- Silent myocardial ischemia is a significant risk factor for major adverse cardiac events.
- Proposed mechanisms involve increased myocardial oxygen demand and dynamic coronary artery abnormalities.
- Treatment options range from risk factor modification to surgical intervention.
Conclusions:
- Silent myocardial ischemia requires effective management strategies.
- Further research is needed to understand plaque activation and endothelial dysfunction in coronary heart disease.
- Comprehensive treatment approaches are essential for improving patient outcomes.
Abstract:
Silent myocardial ischemia, an important contributor to myocardial infarction, sudden cardiac death, ischemic arrhythmias, and other aspects of cardiac morbidity and mortality, requires treatment. Two pathophysiologic mechanisms have been proposed to explain transient, acute episodes of myocardial ischemia: an increase in myocardial demand in coronary obstructive disease and a transient dynamic stenosis or increase in tone within the epicardial coronary arteries. Epidemiologic data suggest a high prevalence of asymptomatic myocardial ischemia, and that these episodes are associated with the morbid events of ischemic heart disease. Several choices exist for the treatment of the condition: conservative (risk factor modification), moderate (medical intervention, percutaneous transluminal angioplasty), and aggressive (coronary artery bypass graft). Further research will elucidate the mechanisms by which the dormant atherosclerotic plaque is transformed to a complicated and activated plaque, and by which endothelial dysfunctions contribute to coronary heart disease.